BRISTOL-MYERS SQUIBB CO
Action · US1101221083 · BMY · 850501 (XNYS)
48,36 USD
06.06.2025 22:18
Cours actuels de BRISTOL-MYERS SQUIBB CO
Bourse | Ticker | Devise | Dernier échange | Cours | Variation journalière |
---|---|---|---|---|---|
![]() NYSE |
BMY
|
USD
|
06.06.2025 22:18
|
48,36 USD
| 47,84 USD
+1,09 %
|
![]() XETRA |
BRM.DE
|
EUR
|
06.06.2025 15:35
|
42,45 EUR
| 42,31 EUR
+0,32 %
|
Performance
Jour | Semaine | Mois | 3 mois | 6 mois | 1 an | 5 ans |
---|---|---|---|---|---|---|
0,00 % | 0,14 % | 1,34 % | -19,15 % | -18,10 % | 16,70 % | -21,15 % |
Profil de l'entreprise pour BRISTOL-MYERS SQUIBB CO Action
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple myeloma; Eliquis, an oral inhibitor for reduction in risk of stroke/systemic embolism in NVAF, and for the treatment of DVT/PE; Opdivo for anti-cancer indications; Pomalyst/Imnovid indicated for patients with multiple myeloma; and Orencia for adult patients with active RA and psoriatic arthritis. It also provides Sprycel for the treatment of Philadelphia chromosome-positive chronic myeloid leukemia; Yervoy for the treatment of patients with unresectable or metastatic melanoma; Abraxane, a protein-bound chemotherapy product; Reblozyl for the treatment of anemia in adult patients with beta thalassemia; and Empliciti for the treatment of multiple myeloma. In addition, the company offers Zeposia to treat relapsing forms of multiple sclerosis; Breyanzi, a CD19-directed genetically modified autologous T cell immunotherapy for the treatment of adult patients with relapsed or refractory large B-cell lymphoma; Inrebic, an oral kinase inhibitor indicated for the treatment of adult patients with myelofibrosis; and Onureg for the treatment of adult patients with AML. It sells products to wholesalers, distributors, pharmacies, retailers, hospitals, clinics, and government agencies. The company was formerly known as Bristol-Myers Company. The company was founded in 1887 and is headquartered in New York, New York.
Fonds investis
Les fonds suivants ont investi dans : BRISTOL-MYERS SQUIBB CO investi :
Fonds | Vol. en millions 34.308,76 | Part (%) 2,38 % |
Fonds | Vol. en millions 6.889,62 | Part (%) 1,89 % |
Fonds | Vol. en millions 2.069,92 | Part (%) 1,68 % |
Fonds | Vol. en millions 598,56 | Part (%) 1,26 % |
Fonds | Vol. en millions 2.556,87 | Part (%) 0,98 % |
Données de l'entreprise
Nom BRISTOL-MYERS SQUIBB CO
Société Bristol-Myers Squibb Company
Symbole BMY
Site web
https://www.bms.com
Marché d'origine
NYSE

WKN 850501
ISIN US1101221083
Type de titre Action
Secteur Healthcare
Industrie Drug Manufacturers - General
PDG Dr. Christopher S. Boerner Ph.D.
Capitalisation boursière 89 Mrd.
Pays États-Unis d'Amérique
Devise USD
Employés 34,1 T
Adresse 430 East 29th Street, 10016 New York
Date d'introduction en bourse 1999-05-14
Dividendes de 'BRISTOL-MYERS SQUIBB CO'
Date ex-dividende | Dividende par action |
---|---|
04.04.2025 | 0,62 USD |
03.01.2025 | 0,62 USD |
04.10.2024 | 0,60 USD |
05.07.2024 | 0,60 USD |
04.04.2024 | 0,60 USD |
04.01.2024 | 0,60 USD |
05.10.2023 | 0,57 USD |
06.07.2023 | 0,57 USD |
06.04.2023 | 0,57 USD |
05.01.2023 | 0,57 USD |
Fractionnements d'actions
Date | Fractionnement |
---|---|
07.08.2001 | 1000000:951777 |
01.03.1999 | 2:1 |
03.03.1997 | 2:1 |
10.06.1987 | 2:1 |
27.05.1983 | 2:1 |
31.05.1977 | 2:1 |
Symboles boursiers
Nom | Symbole |
---|---|
Frankfurt | BRM.F |
NYSE | BMY |
XETRA | BRM.DE |
Autres actions
Les investisseurs qui détiennent BRISTOL-MYERS SQUIBB CO ont également les actions suivantes dans leur portefeuille :
La plateforme financière MoneyPeak suit et analyse les investissements et les portefeuilles.
Du dépôt de titres à l'achat de crypto.
Utile, simple et gratuit. Actions, ETF, ETC, ETN, indices, fonds, obligations, certificats, devises, options, droits de souscription.
Utile, simple et gratuit. Actions, ETF, ETC, ETN, indices, fonds, obligations, certificats, devises, options, droits de souscription.